Additionally, Zhu et al. (2022) reported that high expression levels of ALDH1B1 are associated with poor overall and progression-free survival rates for patients with nasopharyngeal carcinoma [158]. This evidence concerns the gene ALDH1B1 and nasopharyngeal carcinoma.